Vitamin E for rheumatoid arthritis inflammation
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This study tests whether adding vitamin E to standard rheumatoid arthritis treatment can reduce inflammation and disease activity. It is designed for women with early RA who are not getting enough vitamin E from their diet.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female and over 18 years old
- You have early rheumatoid arthritis (diagnosed within the last 2 years)
- You currently take standard RA medications like methotrexate or hydroxychloroquine
- Your RA is moderately to highly active (DAS28 score of 3.2 or higher)
- You do not take vitamin E or iron supplements, aspirin, steroids, or other specified medicines
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether an anti-inflammatory diet can help people with rheumatoid arthritis by lowering inflammation and disease activity. You may join if your symptoms are currently mild to moderate and you haven’t recently changed medications or your treatment plan.
This study tests whether combining resistance exercise (like strength training) with an anti-inflammatory diet can help reduce pain, improve daily function, and boost quality of life for people with rheumatoid arthritis.
This trial tests if taking a vitamin B3 supplement (nicotinamide) can improve outcomes for people with rheumatoid arthritis. Researchers want to see if adding this over-the-counter vitamin to your usual arthritis medicines helps reduce disease activity.
This trial tests an experimental drug for people with rheumatoid arthritis who have not had success with other treatments. It aims to see if the drug can help reduce joint pain and swelling.
This study tests whether two drugs—roflumilast and desloratadine—added to your current rheumatoid arthritis medications can reduce joint inflammation and pain. You'd take these as add-ons to your existing treatment to see if they help control your disease better.
This trial tests a new medication (BMS-986454) for people with rheumatoid arthritis who haven't responded well enough to methotrexate. It aims to see if the drug is safe and how it works in the body.
Hear when a new Rheumatoid arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.